Plasma hypercoagulability in haemodialysis patients: Impact of dialysis and anticoagulation

Nephrology Dialysis Transplantation

Volumn 12, Issue 11, 1997, Pages 2355-2364

  Ambühl, Patrice M ^a,d   Wüthrich, Rudolf P ^b   Korte, Wolfgang ^c   Schmid, Luzius ^c   Krapf, Reto ^a  

^a Kantonsspital ^*  (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Kantonsspital   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Blood coagulation; Erythropoietin; Haemodialysis; Heparin; Prothrombin fragments; Thrombin antithrombin complex

Indexed keywords

ANTITHROMBIN; D DIMER; HEPARIN; POLYSULFONE; PROTHROMBIN; RECOMBINANT ERYTHROPOIETIN; THROMBIN; THROMBOPLASTIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; FEMALE; FIBRINOLYSIS; HEMODIALYSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; MORBIDITY; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; THROMBOSIS;

ADULT; AGE FACTORS; AGED; ANTICOAGULANTS; ANTITHROMBIN III; BLOOD COAGULATION; ERYTHROPOIETIN, RECOMBINANT; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PEPTIDE HYDROLASES; RENAL DIALYSIS;

EID: 0030665973     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.11.2355     Document Type: Article

References (24)

1. Llach F. Hypercoagulability, renal vein thrombosis and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 36: 272-279
2. Vaziri ND, Branson HE, Ness R. Changes of coagulation factors IX, VIII, VII, X and V in nephrotic syndrome. Am J Med Sci 1980; 280: 167-171
3. Faioni EM, Franchi F, Krachmalnicoff A, Valsecchi C, Vigiano GL, Remuzzi G, Manucci PM. Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: An inhibitor of protein C is present in uremic plasma. Thromb Haemost 1991; 66: 420-425
4. Tomura S, Nakamura Y, Deguchi F, Ando R, Chida Y, Marumo F. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment. Thromb Res 1991; 64: 81-90
5. Hafner G, Swars H, Ehrenthal W, Schinzel H, Weilemann LS, Prellwitz W. The control of anti-coagulation in acute dialyses with sensitive laboratory parameters. Scand J Clin Lab Invest 1992; 52: 289-296
6. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993; 63: 273-278
7. Gordge MP, Leaker BR, Rylance PB, Neild GH. Haemostatic activation and proteinuria as factors in the progression of chronic renal failure. Nephrol Dial Transplant 1991; 6: 21-26
8. Butterly DW. A quality improvement program for haemodialysis vascular access. Adv in Renal Repl Therapy 1994; 1: 163-166
9. Kario K, Matsuo T, Yamada T, Nakao K, Shimano C, Matsuo M. Factor VII hyperreactivity in chronic dialysis patients. Thromb Res 1992; 67: 105-113
10. Carter CJ, Doyle DL, Dawson N, Fowler S, Devine DV. Investigations into the clinical utility of latex D-dimer in the diagnosis of deep venous thrombosis. Thromb Haemost 1993; 69: 8-11
11. Boneu B, Bes G, Pelzer H, Sié P, Boccalon H. D-dimers, thrombin antrithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemos 1991; 65: 28-32
12. Sørensen JV, Lassen MR, Borris LC, Rahr HB, Jensen HP, Hoppensteadt D, Walenga JA, Fareed J. Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparin. Blood Coagulation and Fibrinolysis 1992; 3: 55-59
13. Van Wersch JWJ, van Mourik-Alderliesten CH, Coremans A. Comparison of markers of coagulation activation in patients under oral anticoagulation at different levels. Eur J Clin Chem Clin Biochem 1992; 30: 461-466
14. Korte W et al. Vollautomatisierte PTT-Bestimmung. GIT Labor-Medizin 1992; 5: 193-198
15. Bruhn HD, Conrad J, Manucci M, Monteagudo J, Pelzer H, Reverter JC, Samama M, Tripodi A, Wagner C. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination. Thromb Haemostas 1992; 68: 413-417
16. Bauer K, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of haemostatic system activation [Review]. Blood 1987; 70: 343-349
17. Pelzer H et al. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 1988; 59: 101-106
18. Gaffney PJ, Brasher M. Subunit structure of the plasmin-induced degradation products of crosslinked fibrin. Biochimica et Biophysica Acta 1973; 295: 308-313
19. Taylor JE, Belch JJF, McLaren M, Henderson IS, Stewart WK. Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in haemodialysis patients. Kidney Int 1993; 44: 182-190
20. Huraib S, Al-Momen AK, Gader AM, Mitwalli A, Sulimani F, Abu-Aisha H. Effect of recombinant human erythropoietin (rhEPO) on the hemostatic system on chronic hemodialysis patients. Clin Nephrol 1991; 36: 252-257
21. Eberst ME and Berkowitz LR. Hemostasis in renal disease: pathophysiology and management. Am J of Med 1994; 96: 168-179
22. Vaziri ND, Gonzales EC, Wang J, Said S. Blood coagulation, fibrinolytic, and inhibtory proteins in end-stage renal disease: effect of hemodialysis. Am J Kidney Dis 1994; 23: 828-835
23. Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation. Clin Nephrology 1991; 35: 26-34
24. Rugman FP, Jenkins JA, Duguid JK, Maggs PB, Hay CR. Prothrombin fragment F1+2: correlations with cardiovascular risk factors. Blood Coagulation and Fibrinolysis 1994; 5: 335-340